Identification of an FGFR1 Sparing, Reversible, FGFR2 Clinical Development Candidate with Potency Against Gatekeeper and Molecular Brake Mutations

AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Scroll to Top
Scroll to Top